Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Omega Therapeutics, Inc. | Chief Legal and Administrative Officer | Stock Option (Right to Buy) | 125K | Feb 7, 2024 | Direct | ||
Dicerna Pharmaceuticals Inc | Chief Legal Officer & Sec'y | Common Stock | 0 | $38.25 | Dec 28, 2021 | Direct | |
Dicerna Pharmaceuticals Inc | Chief Legal Officer & Sec'y | Restricted Stock Units | 0 | Dec 28, 2021 | Direct | ||
Dicerna Pharmaceuticals Inc | Chief Legal Officer & Sec'y | Employee Stock Option (Right to Buy) | 0 | Dec 28, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OMGA | Omega Therapeutics, Inc. | Feb 7, 2024 | 1 | $0 | 4 | Feb 9, 2024 | Chief Legal and Administrative Officer |
OMGA | Omega Therapeutics, Inc. | Feb 28, 2023 | 1 | $0 | 4 | Mar 2, 2023 | Chief Legal and Administrative Officer |
OMGA | Omega Therapeutics, Inc. | Oct 27, 2022 | 1 | $0 | 4 | Oct 28, 2022 | Chief Legal and Administrative Officer |
OMGA | Omega Therapeutics, Inc. | Mar 31, 2022 | 1 | $0 | 4 | Apr 1, 2022 | Chief Legal and Administrative Officer |
OMGA | Omega Therapeutics, Inc. | Mar 28, 2022 | 0 | $0 | 3 | Apr 1, 2022 | Chief Legal and Administrative Officer Exhibit 24 - Power of Attorney. |
DRNA | Dicerna Pharmaceuticals Inc | Dec 28, 2021 | 5 | -$192K | 4 | Dec 29, 2021 | Chief Legal Officer & Sec'y |
DRNA | Dicerna Pharmaceuticals Inc | Dec 15, 2021 | 3 | -$28.6K | 4 | Dec 17, 2021 | Chief Legal Officer & Sec'y |
DRNA | Dicerna Pharmaceuticals Inc | Sep 15, 2021 | 3 | -$28.6K | 4 | Sep 17, 2021 | Chief Legal Officer & Sec'y |